Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease

被引：0
作者：
Tang, Mengyao [1 ,2 ]
Morieri, Mario Luca [3 ]
Kalim, Sahir [1 ,2 ]
Doria, Alessandro [2 ,4 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] Univ Padua, Dept Med, Padua, Italy
[4] Joslin Diabet Ctr, Res Div, Boston, MA 02215 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2025年
关键词：
diabetic kidney disease;
D O I：
10.1681/ASN.0000000620
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：726 / 729
页数：4
相关论文
共 50 条
  • [1] Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Li, Jiahua
    Albajrami, Oltjon
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1678 - 1688
  • [2] Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Winiarska, Agata
    Knysak, Monika
    Nabrdalik, Katarzyna
    Gumprecht, Janusz
    Stompor, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [3] Combination therapy with SGLT2 inhibitors for diabetic kidney disease
    Cai, Yuwen
    Liu, Xin
    Xu, Gaosi
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [4] Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease
    Georgianos, Panagiotis I.
    Vaios, Vasilios
    Roumeliotis, Stefanos
    Leivaditis, Konstantinos
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [5] SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
    Honghong Zou
    Baoqin Zhou
    Gaosi Xu
    Cardiovascular Diabetology, 16
  • [6] SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
    Zou, Honghong
    Zhou, Baoqin
    Xu, Gaosi
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [7] Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation
    Rroji, Merita
    Spahia, Nereida
    Figurek, Andreja
    Spasovski, Goce
    BIOMEDICINES, 2025, 13 (03)
  • [8] Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
    Puglisi, Soraya
    Rossini, Alessandro
    Poli, Roberta
    Dughera, Francesca
    Pia, Anna
    Terzolo, Massimo
    Reimondo, Giuseppe
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [9] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [10] GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
    Gorriz, Jose Luis
    Jose Soler, Maria
    Navarro-Gonzalez, Juan F.
    Garcia-Carro, Clara
    Jesus Puchades, Maria
    D'Marco, Luis
    Martinez Castelao, Alberto
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    Gorriz-Zambrano, Carmen
    Navarro-Perez, Jorge
    Jose Gorgojo-Martinez, Juan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
12345